Key result
The 9p21 rs7865618 allele A is linked to ~40% higher MI risk versus wild-type.
Why the study?
The 9p21 locus correlates with CAD in European populations, but data have been lacking for Eastern Europeans.
Case-Control (n=757)
Effect estimate: OR 1.40 (95% CI 1.04-1.70)
Absolute Event Rate: 65.08% vs 58.28%
p-value: p=0.019
The study extends evidence that the rs7865618 polymorphism in the 9p21 locus is associated with an increased risk of myocardial infarction in the Bulgarian population.
Should not change MI risk assessment; extends 9p21 associations to Bulgarians but leaves replication open.
Objective The variant 9p21 is correlated with coronary artery disease (CAD) in multiple studies in the European population, but we lack information for the Eastern Europeans (Caucasian). We aimed at investigating the potential association of six common polymorphic variants in 9p21 locus (rs7865618, rs1537378, rs7857345, rs10757274, rs2383206, and rs10757278) with CAD in the Bulgarian population. Materials and methods The current analysis included 261 patients with angiographically documented CAD (153 with myocardial infarction and 108 without myocardial infarction) and 496 population controls. Genomic DNA was isolated from peripheral venous blood. The selected polymorphic variants in 9p21 locus were genotyped by high resolution melting (HRM) analyses (Rotor Gene, Qiagen). Allelic and genotypic frequencies for studied variants were compared between cases and controls using the X 2 test. Results No deviation from the Hardy-Weinberg was observed for all polymorphic variants in both patient’ and control’ groups (p > 0.05). Polymorphic allele A for rs7865618 was found to be higher in the patient group than in the population controls (65.08% vs 58.28%). The carrier of this allele poses a 1.4-fold higher risk of myocardial infarction development than wild-type alleles‘ carriers (OR 1.40 (A) CI 1.04-1.70, p = 0.019), and this dependence is not related with gender. In female, an association between the allele C of rs7857345 and a 1.64-fold increased risk of myocardial infarction was observed (OR 1.64, CI95: 1.03-2.61, p = 0.03). For the other studied polymorphisms, no statistically significant association with disease risk was found. Also, our study found a positive association between rs2383206 and decreased serum triglyceride levels and with serum level of LDL cholesterol. Conclusion Further studies with a larger number of cases and controls will be needed in order to evaluate the possible association between the six studied polymorphisms and CAD/MI in Bulgarians.
No takes yet. Share an insight, caveat, or question.
Tzveova et al. (2025) conducted a case-control in Coronary artery disease and myocardial infarction (n=757). 9p21 locus polymorphic variant rs7865618 (allele A) vs. Wild-type alleles was evaluated on Myocardial infarction development (OR 1.40, 95% CI 1.04-1.70, p=0.019). The polymorphic allele A of rs7865618 in the 9p21 locus was associated with a 1.4-fold higher risk of myocardial infarction compared to wild-type alleles in the Bulgarian population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: